Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

KZR-616, a dual immunoproteasome subunit inhibitor for autoimmune diseases

Jan. 24, 2019

Bio-Thera begins phase III study of tocilizumab biosimilar BAT-1806

Jan. 23, 2019

Anti-SIRT1 autoantibodies as a marker for ankylosing spondylitis diagnosis

Jan. 16, 2019

Pluristem reports successful case study in treatment of Buerger's disease patient

Jan. 11, 2019

Idorsia begins multiple-dose study of cenerimod for SLE

Jan. 7, 2019

Galapagos initiates phase IIa study of GLPG-1690 in systemic sclerosis

Jan. 7, 2019

Discovery and characterization of novel CID peptidomimetic, DB-550

Jan. 4, 2019

Transcription factor suppresses immunity, halts lupus in mice

Dec. 31, 2018

Momenta initiates phase II trial of M-281 in generalized myasthenia gravis

Dec. 27, 2018

FDA approves IND for anti-GM-CSF monoclonal antibody TJM2

Dec. 24, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...